Stock VINC VINCERX PHARMA, INC.
Add to a list
To use this feature you must be a member
Log inSign up

All News Vincerx Pharma, Inc.

Equities

VINC

US92731L1061

Market Closed - Nasdaq
Other stock markets
 04:00:00 2024-07-12 pm EDT 		5-day change 1st Jan Change
0.6928 USD +4.97% Intraday chart for Vincerx Pharma, Inc. -7.60% -41.29%
May. 14 Vincerx Pharma, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
Apr. 26 Tech Rally Boosts Exchange-Traded Funds, Equity Futures Pre-Bell Friday MT

All News

Search
See the results
Unlock all the news: Be the first to know and act before the market!
100% Free Registration
Vincerx Pharma, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024
CI
Vincerx Pharma Reports First Quarter 2024 Financial Results and Provides Corporate Update
AQ
Tech Rally Boosts Exchange-Traded Funds, Equity Futures Pre-Bell Friday
MT
Vincerx Pharma Prices Public Offering of Shares, Warrants
MT
Vincerx Pharma Announces Pricing of Underwritten Public Offering of Common Stock and Warrants
AQ
Vincerx Pharma Announces Proposed Underwritten Public Offering of Common Stock and Warrants
AQ
Wall Street Set to Open Slightly Higher as Investors Await Wednesday's Inflation Data
MT
Top Premarket Decliners
MT
Investors Eye Wednesday Inflation Data as US Futures Tread Water Tuesday Pre-Bell
MT
Vincerx Pharma Presents Positive Preliminary Phase 1 Data for VIP236 and Updates on Pipeline Progress at the American Association for Cancer Research (AACR) Annual Meeting 2024 
AQ
Vincerx Pharma, Inc. Presents Positive Preliminary Phase 1 Data for Vip236 and Updates on Pipeline Progress At the American Association for Cancer Research Annual Meeting 2024
CI
Vincerx to Host Virtual Investor Event Reviewing Preliminary Phase 1 VIP236 Data Presented at the American Association for Cancer Research (AACR) Annual Meeting 2024
AQ
Vincerx Pharma Reports Fourth Quarter and Full Year 2023 Financial Results and Corporate Update
AQ
Vincerx Pharma, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023
CI
North American Morning Briefing : Tech in Focus on -2-
DJ
Vincerx to Present Three Posters at the American Association for Cancer Research (AACR) Annual Meeting 2024
AQ
Vincerx Pharma Shares Jump After Results of Blood Cancer Treatment Trial
MT
Top Premarket Gainers
MT
Vincerx Pharma Announces Compelling Clinical Efficacy of Enitociclib in Combination with Venetoclax and Prednisone in Lymphoma
AQ
Vincerx Pharma, Inc. Announces Compelling Clinical Efficacy of Enitociclib in Combination with Venetoclax and Prednisone in Lymphoma
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. VINC Stock
  4. News Vincerx Pharma, Inc.